Gottlieb Q&A: Off-Label Communications And Right-To-Try

US FDA Commissioner nominee favors making up-to-date, accurate information available to patients and providers, but will that translate to more freedom for sponsor communications?

RulesRegulationsBooks_1200x675

Scott Gottlieb admitted to not being fully briefed on the US FDA's off-label communications issues, but seems interested in policy tilting toward more information disclosure on drug uses.

The nominee for FDA Commissioner indicated in answers to written questions submitted by members of the Senate Health, Education, Labor...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Marketing & Advertising

More from Compliance